SRM and breast carcinoma: Paclitaxel treatment elevated intracellular levels of ornithine and total polyamine (including putrescine, spermidine, and spermine) (Figure 2E; Figure S2B, Supporting Information), and increased expression of ODC1 and SRM (but not SMS) (Figure 2F) in breast cancer cell lines.